Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
ELVN-002 + Trastuzumab for HER2+ Colorectal and Breast Cancer
Recruiting1 awardPhase 1
Saint Louis, Missouri
This trial aims to find out how safe and well-tolerated ELVN-002 is when given with trastuzumab in patients with advanced HER2-positive tumors. It also seeks to determine
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service